Numans Health Food Holdings Company Limited (NUMANS) has scheduled a board meeting for 30 April 2026 to review and approve its consolidated financial results for the year ended 31 December 2025, as well as to consider a possible final dividend.
Trading in NUMANS shares has been suspended since 9:00 a.m. on 1 April 2026 and will remain halted until the FY 2025 results are released. The suspension follows the company’s 31 March 2026 disclosure regarding the delay in publishing its annual results.
The current board comprises Chairman Wang Ping and Executive Director Cui Juan, Non-Executive Director Chan Hok Leung, and Independent Non-Executive Directors Yim Wing Yee, Lau Kwok Fai Patrick, and Yu Tsz Ngo.